A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection

Clinical trial NCT03083743 · UNKNOWN

Trial details

NCT number: NCT03083743
Sponsor: Shanghai Gebaide Biotechnology Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Non-small-cell Lung Cancer (NSCLC) Stage IV

Start date: 2016-10-01
Primary completion: 2017-10-01
Enrollment: 417

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.